Cite
HARVARD Citation
Sarzi-Puttini, P. et al. (2006). Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. Annals of the rheumatic diseases. 65 (3), pp. 301-305. [Online].